S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apria, Inc. stock logo
APR
Apria
$37.50
$37.45
$22.36
$40.00
$1.34BN/A682,285 shsN/A
Bioventus Inc. stock logo
BVS
Bioventus
$4.55
-3.2%
$4.97
$0.86
$6.08
$360.22M0.5147,150 shs106,628 shs
FTC Solar, Inc. stock logo
FTCI
FTC Solar
$0.38
-7.3%
$0.52
$0.28
$3.87
$47.57M1.62723,218 shs566,420 shs
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
$1.26
+1.6%
$1.41
$1.02
$7.64
$60.81M0.33376,609 shs184,589 shs
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
$9.61
$9.72
$13.19
$1.04BN/A1.40 million shs1.83 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apria, Inc. stock logo
APR
Apria
0.00%0.00%0.00%0.00%0.00%
Bioventus Inc. stock logo
BVS
Bioventus
-3.19%-5.41%-15.74%-5.21%+321.30%
FTC Solar, Inc. stock logo
FTCI
FTC Solar
-6.51%-21.48%-29.17%-27.66%-85.42%
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
+1.61%-8.70%-16.00%-17.11%-74.70%
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/AN/AN/AN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
3.4939 of 5 stars
3.50.00.00.02.54.21.9
FTC Solar, Inc. stock logo
FTCI
FTC Solar
1.7465 of 5 stars
3.20.00.00.01.14.21.3
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
1.8221 of 5 stars
3.53.00.00.00.01.71.3
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
3.00
Buy$7.6768.50% Upside
FTC Solar, Inc. stock logo
FTCI
FTC Solar
2.43
Hold$1.49292.03% Upside
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
3.00
Buy$9.50653.97% Upside
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/AN/AN/AN/A

Current Analyst Ratings

Latest BVS, APR, TBA, FTCI, and IKNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/19/2024
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
3/14/2024
FTC Solar, Inc. stock logo
FTCI
FTC Solar
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$2.50 ➝ $1.50
3/14/2024
FTC Solar, Inc. stock logo
FTCI
FTC Solar
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/14/2024
FTC Solar, Inc. stock logo
FTCI
FTC Solar
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$2.00 ➝ $0.45
3/13/2024
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $9.00
3/12/2024
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$8.00
1/19/2024
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$8.00
1/19/2024
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apria, Inc. stock logo
APR
Apria
$1.15B1.17$5.27 per share7.12$1.12 per share33.48
Bioventus Inc. stock logo
BVS
Bioventus
$512.34M0.70$0.78 per share5.87$2.80 per share1.63
FTC Solar, Inc. stock logo
FTCI
FTC Solar
$127M0.37N/AN/A$0.50 per share0.76
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
$9.16M6.64N/AN/A$3.52 per share0.36
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apria, Inc. stock logo
APR
Apria
$64.88MN/A0.0020.49N/A5.66%586.18%9.23%N/A
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23M-$2.52N/A11.38N/A-30.49%2.25%0.62%5/21/2024 (Estimated)
FTC Solar, Inc. stock logo
FTCI
FTC Solar
-$50.29M-$0.43N/AN/AN/A-39.60%-59.79%-31.71%5/8/2024 (Estimated)
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
-$68.17M-$1.64N/AN/AN/AN/A-44.21%-37.27%5/20/2024 (Estimated)
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
-$30KN/A0.00N/AN/AN/AN/AN/AN/A

Latest BVS, APR, TBA, FTCI, and IKNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/13/2024Q4 2023
FTC Solar, Inc. stock logo
FTCI
FTC Solar
-$0.08-$0.07+$0.01-$0.05$22.80 million$23.20 million    
3/12/2024Q4 2023
Bioventus Inc. stock logo
BVS
Bioventus
$0.06$0.07+$0.01$0.24$124.84 million$135.42 million
3/12/2024Q4 2023
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
-$0.41-$0.41N/A-$0.41$2.39 million$0.66 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/AN/A
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
FTC Solar, Inc. stock logo
FTCI
FTC Solar
N/AN/AN/AN/AN/A
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
N/AN/AN/AN/AN/A
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apria, Inc. stock logo
APR
Apria
8.58
1.09
1.06
Bioventus Inc. stock logo
BVS
Bioventus
1.66
1.53
1.01
FTC Solar, Inc. stock logo
FTCI
FTC Solar
N/A
1.99
1.91
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
N/A
12.58
12.58
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/A
1.38
1.38

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apria, Inc. stock logo
APR
Apria
N/A
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
FTC Solar, Inc. stock logo
FTCI
FTC Solar
45.36%
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
75.00%
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/A

Insider Ownership

CompanyInsider Ownership
Apria, Inc. stock logo
APR
Apria
N/A
Bioventus Inc. stock logo
BVS
Bioventus
29.10%
FTC Solar, Inc. stock logo
FTCI
FTC Solar
29.70%
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
5.95%
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apria, Inc. stock logo
APR
Apria
6,08035.65 millionN/ANot Optionable
Bioventus Inc. stock logo
BVS
Bioventus
97079.17 million56.13 millionNot Optionable
FTC Solar, Inc. stock logo
FTCI
FTC Solar
213125.01 million87.88 millionOptionable
Ikena Oncology, Inc. stock logo
IKNA
Ikena Oncology
4348.26 million45.39 millionNot Optionable
Thoma Bravo Advantage stock logo
TBA
Thoma Bravo Advantage
N/A102.40 millionN/ANot Optionable

BVS, APR, TBA, FTCI, and IKNA Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apria logo

Apria

NYSE:APR
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.
Bioventus logo

Bioventus

NYSE:BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.
FTC Solar logo

FTC Solar

NASDAQ:FTCI
FTC Solar, Inc. engages in the provision of solar tracker systems, software, and engineering services in the United States, Asia, Europe, the Middle East, North Africa, South Africa, and Australia. The company offers a self-powered, two-panel in-portrait, and single-axis tracker solution under the Voyager brand name; and a one module-in-portrait solar tracker solution under the Pioneer brand name. Its customers include project developers and solar asset owners, as well as engineering, procurement, and construction contractors that design and build solar energy projects. The company was incorporated in 2017 and is headquartered in Austin, Texas.
Ikena Oncology logo

Ikena Oncology

NASDAQ:IKNA
Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway. The company also develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Thoma Bravo Advantage logo

Thoma Bravo Advantage

NYSE:TBA
Thoma Bravo Advantage does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Chicago, Illinois.